Funder: NIH Multiple ICs – check FOA for full list

The purpose of this funding opportunity is to provide an opportunity for funded researchers in these various fields to pursue supplemental funding to conduct research addressing these emerging and other existing COVID-related issues among pregnant and lactating people, infants, children and adolescents, and individuals with physical and/or intellectual disabilities. The goal of this NOSI is to not replace or to compete with the various COVID-related funding opportunities currently available. Instead, the purpose is to complement them by offering a funding opportunity for currently funded investigators to address key issues not currently covered by available COVID-related funding announcements among these populations. It is hoped that the use of administrative supplements will foster research in these key areas in the most timely manner. Research projects addressing issues that are the focus of currently available or future COVID funding opportunity announcements will be encouraged to submit to those announcements. Also, applicants responding to this NOSI are strongly encouraged to describe plans for the rapid sharing of data and results as well as innovative data analytics approaches. The sharing of COVID-related data and resources and the effective communication of results are a high priority of the NIH.

Topics: Biomarkers, Biospecimen Science, Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, Asthma, Cancer, Cardiovascular Disease, Cirrhosis, COPD, COVID-19, Diabetes, Gastroesophageal Reflux Disease (GERD), Hidradentis Supporativa, Immune Disorders, HIV, Immunosuppression, Inflammation, Rheumatoid Disorders, Neurological Disorders, Substance Abuse, Community Engagement, Computational Analysis, Computational or Data Science Methods Development, Diagnostics, Antibody Detection, Diagnostics Development, Viral Detection, Economic Impact, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Health Disparities, Healthcare Implementation, Immunity, Immunology, Host Factors, Host Response, Impact to Conduct of Research, Pandemic Context, Mental Health, Psychology, Mobile Health, App, Telemedicine, Wearables, Occupational Health, Oral Science / Dentistry, Organ, Brain, Endocrine, Eye, GI, Heart, Cardiovascular, Kidney, Liver, Lung, Oral Cavity, Skin, Prevention, PPE, Social Distancing, Product Development and Commercialization, Prognostics, Research Facilities Development, Research Methods, Cell Culture, Electronic Health Records (EHR), Imaging, Immunofluorescence, Screen, Sequencing, Research Model Development, Research Models, Mouse Models, Non-Human Animal Models, Organoid Models, Research Site, Community-based, International, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors, Vaccine Development, Vaccines, Vaccine Hesitancy, Research Tool Development, Social Determinants of Health, Target Population, Children, Deaf Persons, Elderly, Homeless Persons, Pregnant Women, Teens, Visually Impaired, Treatments, Drugs, Antibody-based Treatment, Convalescent Serum, Drug Development, Drug Repurposing, Drug Targets, Immunological Response Targets, Anti-viral Targets